Misoprostol approved by European Medicines Agency for PPH treatment
Misoprostol was approved for PPH treatment at a dose of 800mcg sublingually by the European Medicines Agency in April 2014. The link to the EMA documents can be found here: Hemoprostol H-W-2652
Comments are closed.